High Troponin Levels: Causes, Laboratory Interpretation, Delta Change, False Positives, ACS vs Non-ACS & Case Studies (2026)
Cardiac troponin is one of the most important biomarkers in modern laboratory medicine. High-sensitivity cardiac troponin assays have transformed the evaluation of patients with suspected acute coronary syndrome by detecting very small concentrations of myocardial injury.
However, one of the most important principles for laboratory professionals and clinicians is: an elevated troponin concentration does not automatically mean acute myocardial infarction.
Troponin elevation indicates myocardial injury. The clinical diagnosis of myocardial infarction requires interpretation of the troponin pattern together with evidence of acute myocardial ischemia, such as symptoms, electrocardiographic findings, imaging findings, or coronary thrombus depending on the clinical situation.
In this comprehensive MedLab Academy guide, we review cardiac troponin biology, hs-cTnI versus hs-cTnT, the 99th percentile upper reference limit, delta change, acute versus chronic myocardial injury, ACS versus non-ACS causes, kidney disease, sepsis, pulmonary embolism, analytical interference, false-positive and false-negative results, laboratory quality control, result verification, and practical case studies.
1. What Is Cardiac Troponin?
Troponins are regulatory proteins involved in skeletal and cardiac muscle contraction. The troponin complex contains three major components: troponin C, troponin I, and troponin T.
- Troponin C: binds calcium.
- Troponin I: inhibits actin-myosin interaction.
- Troponin T: binds the troponin complex to tropomyosin.
Cardiac-specific forms of troponin I and troponin T are used as biomarkers of myocardial injury.
When cardiomyocytes are injured, cardiac troponin can be released into the circulation. Modern high-sensitivity assays can measure extremely low circulating concentrations and detect myocardial injury earlier than older-generation assays.
2. Cardiac Troponin I vs Cardiac Troponin T
Both cardiac troponin I (cTnI) and cardiac troponin T (cTnT) are well-established markers of myocardial injury. For a broader overview of cardiac laboratory markers, see the Cardiac Biomarkers Complete Guide.
| Feature | cTnI | cTnT |
|---|---|---|
| Cardiac biomarker | Yes | Yes |
| Used for myocardial injury detection | Yes | Yes |
| High-sensitivity assays available | Yes | Yes |
| Assay standardization | Values vary between manufacturers | Platform-specific interpretation required |
| Reference limits | Assay specific | Assay specific |
A critical laboratory principle is that numerical results from different troponin assays should not be assumed to be directly interchangeable. Each assay has its own analytical characteristics, calibration, reportable range, detection capability, and 99th percentile URL.
3. What Does High-Sensitivity Troponin Mean?
The term high-sensitivity cardiac troponin refers to the analytical performance of an assay rather than to a special type of troponin produced by the heart.
High-sensitivity assays can measure troponin concentrations in a large proportion of apparently healthy individuals and provide sufficient precision at very low concentrations to support rapid diagnostic pathways.
The clinical benefit is not simply that an assay can detect a smaller number. Its value lies in detecting small changes over time and allowing earlier assessment of myocardial injury.
4. Understanding the 99th Percentile Upper Reference Limit
The 99th percentile upper reference limit (URL) is a fundamental concept in cardiac troponin interpretation.
Myocardial injury is present when the cardiac troponin concentration exceeds the assay's 99th percentile URL.
However, the exact numerical concentration of the 99th percentile depends on the specific assay and reference population.
Why can reference limits differ?
- Different assay antibodies and designs.
- Different calibration systems.
- Different reference populations.
- Age distribution.
- Sex distribution.
- Criteria used to define apparently healthy individuals.
- Statistical methodology.
Some assays provide sex-specific reference limits. Laboratories should follow validated manufacturer data and their own approved reporting policy.
5. Myocardial Injury vs Myocardial Infarction
This distinction is one of the most important concepts in troponin interpretation.
Myocardial injury
Myocardial injury is present when cardiac troponin exceeds the 99th percentile upper reference limit.
Acute myocardial injury
Acute myocardial injury is characterized by an elevated troponin concentration together with a dynamic rise and/or fall in serial measurements.
Myocardial infarction
Myocardial infarction requires acute myocardial injury plus clinical evidence that the injury is caused by myocardial ischemia.
Evidence may include, depending on the case:
- Symptoms consistent with acute myocardial ischemia.
- New ischemic ECG changes.
- Development of pathological Q waves.
- Imaging evidence of new loss of viable myocardium.
- New regional wall-motion abnormality consistent with ischemia.
- Identification of coronary thrombus in an appropriate setting.
High troponin = myocardial injury.
High troponin does not automatically = myocardial infarction.
6. Acute vs Chronic Myocardial Injury
Serial testing helps distinguish acute injury from persistently elevated troponin concentrations.
| Pattern | Interpretation |
|---|---|
| Troponin above 99th percentile with clear rise/fall | Acute myocardial injury |
| Troponin persistently above 99th percentile with relatively stable values | Chronic myocardial injury may be considered |
| Troponin below URL but changing | Interpret using assay-specific rapid algorithm and clinical context |
Chronic troponin elevation may occur in conditions such as chronic kidney disease, structural heart disease, and chronic heart failure.
The absolute troponin concentration alone cannot reliably identify the cause.
7. Delta Troponin: Why Serial Change Matters
The term delta describes the difference between serial troponin measurements.
For example:
Initial hs-cTn = 12 ng/L
Repeat hs-cTn = 35 ng/L
Absolute delta = 35 − 12 = 23 ng/L.
Absolute vs relative delta
Two approaches are commonly discussed:
- Absolute change: difference in concentration units.
- Relative change: percentage change from the baseline result.
The optimal interpretation depends on the assay, concentration range, sampling interval, and clinical pathway being used.
8. Troponin in Acute Coronary Syndrome
High-sensitivity cardiac troponin is central to the evaluation of suspected non-ST-elevation acute coronary syndrome.
Serial measurements may be incorporated into rapid diagnostic pathways such as 0/1-hour or 0/2-hour strategies, depending on the assay and institutional protocol.
These strategies classify patients using combinations of:
- Initial troponin concentration.
- Repeat concentration.
- Absolute change.
- Time from symptom onset.
- Clinical assessment.
- ECG findings.
Laboratories must ensure that clinicians know which assay is being used because algorithm thresholds are assay dependent.
9. Non-ACS Causes of High Troponin
Many conditions can produce genuine myocardial injury without acute coronary plaque rupture. When systemic inflammation or infection is part of the differential diagnosis, related laboratory markers may also be useful; see our guides to High CRP Levels and Procalcitonin (PCT).
| Category | Examples |
|---|---|
| Cardiac ischemia | Type 1 MI, supply-demand imbalance |
| Heart failure | Acute or chronic heart failure |
| Inflammatory cardiac disease | Myocarditis |
| Arrhythmias | Rapid tachyarrhythmia or severe bradyarrhythmia |
| Pulmonary disease | Pulmonary embolism with right ventricular strain |
| Systemic illness | Sepsis, shock, severe critical illness |
| Renal disease | Chronic kidney disease |
| Structural cardiac disease | Cardiomyopathy and other myocardial disorders |
| Procedural/traumatic | Cardiac procedures, surgery, trauma |
| Physiological stress | Prolonged strenuous endurance exercise in some individuals |
Therefore, the laboratory should avoid language implying that every positive troponin result confirms acute coronary syndrome.
10. High Troponin in Chronic Kidney Disease
Troponin interpretation can be challenging in patients with chronic kidney disease because baseline concentrations may remain above the 99th percentile even without acute myocardial infarction.
Possible contributors include:
- Underlying structural cardiac disease.
- Left ventricular hypertrophy.
- Heart failure.
- Microvascular disease.
- Repeated subclinical myocardial injury.
- Altered handling of troponin-related fragments.
A chronically elevated baseline makes serial change especially important.
11. Troponin Elevation in Sepsis and Critical Illness
Elevated cardiac troponin is frequently observed in severe systemic illness, including sepsis.
Potential mechanisms include:
- Supply-demand mismatch.
- Hypotension.
- Hypoxemia.
- Microvascular dysfunction.
- Inflammatory myocardial injury.
- Direct or indirect myocardial stress.
The presence of elevated troponin in sepsis does not by itself prove acute plaque rupture.
Clinical context, ECG, hemodynamic status, symptoms, imaging, and serial troponin changes remain essential.
12. Pulmonary Embolism and Elevated Troponin
Troponin may become elevated in pulmonary embolism, particularly when there is significant right ventricular strain. For the laboratory approach to suspected venous thromboembolism, see High D-Dimer Levels: DVT & Pulmonary Embolism Diagnosis.
The mechanism differs from the typical coronary mechanism of Type 1 myocardial infarction.
In pulmonary embolism, troponin can contribute to risk assessment when interpreted with clinical findings and cardiac imaging.
13. Myocarditis and Troponin
Myocardial inflammation can cause elevated troponin because injured cardiomyocytes release cardiac troponin into the circulation.
Troponin values may overlap substantially with concentrations seen in other cardiac disorders. Therefore, the concentration alone does not identify the cause of myocardial injury.
Evaluation may include:
- Clinical history.
- ECG.
- Echocardiography.
- Cardiac magnetic resonance imaging.
- Other laboratory investigations.
14. Heart Failure and High Troponin
Patients with acute or chronic heart failure may have elevated cardiac troponin concentrations.
This can reflect ongoing myocardial stress or injury rather than acute coronary occlusion.
Serial patterns and the clinical scenario help determine whether coexisting acute ischemia should be considered.
15. Troponin Elevation After Strenuous Exercise
Transient cardiac troponin elevations have been described following prolonged strenuous endurance exercise.
This emphasizes a broader principle: troponin elevation indicates myocardial injury or troponin release, not a specific disease by itself.
Clinical history is therefore essential when unexpected troponin elevation is encountered.
16. False-Positive Troponin Results
Most elevated troponin values represent genuine detectable cardiac troponin. However, analytical interference can occasionally produce a misleading result.
Laboratory professionals should consider interference when the result is strongly inconsistent with:
- The clinical presentation.
- ECG findings.
- Cardiac imaging.
- Serial pattern.
- Results obtained using another assay platform.
Possible analytical causes include:
- Heterophile antibodies.
- Human anti-animal antibodies.
- Autoantibody interference.
- Macrotroponin.
- Assay-specific interference.
- Biotin-related interference in susceptible assay designs.
- Rare specimen or instrument-related problems.
17. Heterophile Antibody Interference
Heterophile antibodies can interact with antibodies used in immunoassays and occasionally generate falsely elevated or otherwise incorrect troponin results.
When should the laboratory suspect interference?
- Persistent troponin elevation without compatible clinical evidence.
- Stable unusual result over repeated admissions.
- Discordance between cTnI and cTnT.
- Marked difference when testing with another manufacturer's assay.
- Result does not fit imaging, ECG, or clinical findings.
Possible laboratory investigations
- Repeat testing from the original sample.
- Repeat using a freshly collected specimen.
- Testing on an alternative assay platform.
- Serial dilution studies when appropriate.
- Heterophile blocking reagents.
- PEG precipitation in selected investigations.
- Consultation with the assay manufacturer.
18. Macrotroponin
Macrotroponin describes troponin bound to immunoglobulin, creating a larger circulating complex that can persist in the bloodstream and produce chronically elevated results in some assays.
Macrotroponin should be considered particularly when:
- Troponin remains persistently elevated.
- The patient is clinically stable.
- Cardiac investigations repeatedly fail to explain the elevation.
- Different troponin assays show major discordance.
PEG precipitation may help investigate possible macrotroponin, but results require cautious interpretation and laboratory validation.
19. Biotin Interference in Troponin Testing
Biotin is used in some immunoassay designs and high circulating biotin concentrations can interfere with susceptible laboratory tests.
The direction of interference depends on the assay architecture. Importantly, regulatory authorities have specifically warned that biotin can cause falsely low troponin results in some susceptible assays.
This is particularly important because a falsely low cardiac troponin could potentially delay recognition of myocardial injury.
20. Preanalytical Considerations in Troponin Testing
Although troponin testing is highly automated, preanalytical quality remains important.
Patient identification
Correct identification is essential. A perfectly analytical result from the wrong patient is still a serious laboratory error.
Specimen type
Use only specimen types validated for the specific analyzer and reagent system.
Depending on the manufacturer, acceptable materials may include:
- Serum.
- Lithium heparin plasma.
- Other validated plasma types.
Never assume specimen requirements are identical between assays.
Timing
Serial timing matters because rapid clinical pathways depend on accurate collection times.
The LIS should ideally allow clear documentation of:
- Collection time.
- Receipt time.
- Analysis time.
- Result release time.
Sample quality
Hemolysis, lipemia, fibrin, insufficient sample volume, or other specimen problems should be evaluated according to assay-specific interference studies and laboratory policy. For a detailed preanalytical discussion, see Hemolysis in Clinical Chemistry.
21. Analytical Considerations
Assay-specific cutoffs
The laboratory report should use the validated URL for the assay in use.
Units
High-sensitivity troponin is commonly reported in ng/L, but laboratories must verify their platform and reporting policy.
1 ng/L = 1 pg/mL.
Limit of blank, detection, and quantitation
Important analytical concepts include:
- LoB: Limit of Blank.
- LoD: Limit of Detection.
- LoQ: Limit of Quantitation.
- 99th percentile URL: clinical decision reference point for myocardial injury.
These terms are related but are not interchangeable.
Assay comparability
If the hospital changes from one troponin assay to another, the laboratory should evaluate:
- Reference limits.
- Units.
- Reporting format.
- Clinical decision thresholds.
- Rapid algorithms.
- LIS configuration.
- Delta-check rules.
- Clinician education.
22. Quality Control in Cardiac Troponin Testing
Because troponin results can influence urgent clinical management, analytical quality is critical.
Internal Quality Control
The laboratory should run QC according to:
- Manufacturer recommendations.
- Laboratory risk assessment.
- Regulatory and accreditation requirements.
- Local SOPs.
Multiple control levels should adequately monitor clinically relevant concentration ranges.
Review QC before releasing patient results
If QC is unacceptable:
- Do not release affected patient results.
- Review the QC chart.
- Apply the laboratory's QC acceptance rules.
- Check reagent status.
- Check calibration status.
- Inspect instrument flags and maintenance.
- Confirm control preparation and storage.
- Investigate systematic or random error.
- Correct the problem.
- Repeat QC.
- Release patient results only after the system is demonstrated to be acceptable.
- Document the investigation and corrective action.
Levey-Jennings and Westgard principles
Where applicable within the laboratory QC strategy, Levey-Jennings charts and statistical QC rules can help identify these patterns. For a detailed explanation of control charts, Westgard rules, and error detection, see Internal Quality Control (IQC): Westgard Rules & Levey–Jennings Charts.
- Random error.
- Systematic error.
- Shift.
- Trend.
External Quality Assessment
Participation in EQA or proficiency testing provides independent assessment of analytical performance and interlaboratory comparability. Broader laboratory performance monitoring should also include defined quality indicators and KPIs; see Laboratory Quality Indicators (QIs): KPIs, ISO 15189 & Quality Management.
23. Unexpected Troponin Result: What Should the Laboratory Do?
Suppose the clinician contacts the laboratory because a patient's troponin result is unexpectedly high despite a clinical picture that does not suggest acute cardiac injury.
Step 1 — Verify patient and specimen identification
- Patient name.
- Medical record number.
- Sample accession number.
- Collection time.
- Specimen labeling.
Step 2 — Review analytical status
- QC status.
- Calibration status.
- Reagent lot.
- Analyzer flags.
- Maintenance status.
Step 3 — Inspect the specimen
Review any available indices or visual specimen information according to laboratory policy.
Step 4 — Repeat analysis when appropriate
Repeat testing may identify transient analytical problems but does not exclude interference when the same interfering substance is still present.
Step 5 — Test a new sample
A freshly collected sample helps exclude specimen identification or collection problems.
Step 6 — Consider an alternative platform
Major discordance between assays may raise suspicion of assay-specific interference.
Step 7 — Investigate interference
Depending on laboratory capability:
- Heterophile blocking studies.
- PEG precipitation.
- Serial dilution.
- Manufacturer technical support.
Step 8 — Communicate clearly
Discuss findings with the requesting clinician and document significant laboratory investigations.
24. Practical Troponin Interpretation Algorithm
Step 1: Is troponin above the assay's 99th percentile URL?
No: interpret with the appropriate rapid algorithm, time from symptom onset, serial change, ECG, and clinical risk.
Yes: myocardial injury is present. Proceed to Step 2.
Step 2: Is there a significant rise or fall?
Yes: consider acute myocardial injury.
No / relatively stable: consider chronic myocardial injury, depending on the clinical context and serial interval.
Step 3: Is there evidence of myocardial ischemia?
If acute injury is accompanied by clinical evidence of ischemia, myocardial infarction enters the diagnostic framework.
Step 4: If ischemia is absent
Investigate other causes of myocardial injury such as:
- Sepsis.
- Heart failure.
- Kidney disease.
- Pulmonary embolism.
- Myocarditis.
- Arrhythmia.
- Critical illness.
Step 5: Does the result make analytical sense?
If not, investigate possible laboratory interference.
25. Clinical Case Studies
Case 1 — Acute Chest Pain With Rising Troponin
A 58-year-old patient presents with acute central chest pressure.
Initial hs-cTn: 18 ng/L
Repeat hs-cTn: 92 ng/L
ECG demonstrates new ischemic changes.
Interpretation
The dynamic troponin rise demonstrates acute myocardial injury. Combined with clinical evidence of ischemia, acute myocardial infarction must be evaluated according to current diagnostic criteria and local clinical protocols.
Case 2 — Chronic Kidney Disease With Stable Troponin
A patient with advanced chronic kidney disease has:
Initial hs-cTn: 78 ng/L
Repeat: 81 ng/L
Later: 79 ng/L
There are no new ischemic ECG findings.
Interpretation
Persistent elevation with little dynamic change may be more consistent with chronic myocardial injury than a new acute event, although the complete clinical picture remains essential.
The elevated result should not simply be dismissed as a laboratory false positive because the patient has kidney disease.
Case 3 — Sepsis With Elevated Troponin
A critically ill patient with septic shock has elevated hs-cTn. The patient is hypotensive and tachycardic.
Interpretation
Severe systemic illness can cause genuine myocardial injury through multiple mechanisms. Troponin elevation alone does not prove acute coronary plaque rupture. Laboratory interpretation may be strengthened by reviewing complementary inflammatory and infection markers such as Procalcitonin, CRP, and ESR when clinically appropriate.
Case 4 — Persistent Troponin Elevation but Normal Cardiac Workup
A clinically stable patient repeatedly has elevated cTnI during several hospital visits. ECG and cardiac imaging repeatedly fail to explain the result.
The laboratory tests the sample using an alternative troponin assay, which produces a substantially different result.
Laboratory interpretation
Analytical interference should be considered. Possible investigations include heterophile antibody evaluation and macrotroponin studies according to validated laboratory procedures.
Case 5 — Biotin and Unexpectedly Low Troponin
A patient with a compatible clinical presentation produces an unexpectedly low troponin result. Medication and supplement history reveals high-dose biotin exposure.
Laboratory interpretation
If the assay is susceptible to biotin interference, a falsely low result should be considered and investigated according to the current manufacturer instructions.
Case 6 — Pulmonary Embolism With Troponin Elevation
A patient presents with sudden dyspnea and tachycardia. Imaging confirms pulmonary embolism. Troponin is elevated.
Interpretation
The result may reflect right ventricular myocardial injury caused by acute pressure overload. It does not necessarily indicate Type 1 myocardial infarction.
26. Common Laboratory Interpretation Errors
- Calling every elevated troponin an MI. Troponin identifies myocardial injury, not its cause.
- Using one universal cutoff. The 99th percentile is assay specific.
- Ignoring serial change. Dynamic behavior is important in distinguishing acute from chronic injury.
- Using a delta from the wrong platform. Rapid algorithm thresholds must match the assay.
- Ignoring renal disease. Chronic elevations are common but remain clinically meaningful.
- Calling renal troponin elevations false positives. Many represent real myocardial injury.
- Ignoring analytical interference. Rare interference can produce clinically misleading results.
- Assuming repeated analysis excludes interference. The same interfering substance can affect the repeated measurement.
- Ignoring QC status. Patient testing should not proceed on an analytically unacceptable system.
- Comparing different troponin assays numerically as if identical. They are not directly interchangeable.
27. Troponin Reporting: Good Laboratory Practice
A clear troponin report should include:
- Analyte name.
- Result.
- Unit.
- Appropriate reference/decision information.
- Analyzer flags when applicable.
- Relevant interpretive comments approved by the laboratory.
Laboratories should avoid confusing terms and ensure that clinical staff understand any change in assay or reporting limits.
When changing troponin platforms
A laboratory should consider the following verification, reporting, and quality-management elements. Related principles are discussed further in Laboratory Quality Indicators (QIs) and the Internal Quality Control (IQC) Guide.
- Method verification.
- Precision verification.
- Reportable range.
- Reference interval/URL verification.
- Method comparison where applicable.
- Clinical pathway updates.
- LIS configuration.
- Critical or alert communication policies.
- Education of emergency and cardiology teams.
28. Frequently Asked Questions
What does a high troponin level mean?
A cardiac troponin concentration above the assay-specific 99th percentile upper reference limit indicates myocardial injury. It does not by itself identify the cause of that injury.
Does elevated troponin always mean a heart attack?
No. Myocardial infarction requires myocardial injury together with clinical evidence of ischemia. Troponin can also increase in kidney disease, sepsis, heart failure, pulmonary embolism, myocarditis, and other conditions.
What is the normal troponin range?
There is no universal numerical normal range for all cardiac troponin assays. Laboratories must use the assay-specific 99th percentile URL and manufacturer information.
What is hs-troponin?
High-sensitivity troponin refers to an assay capable of reliably measuring very low cardiac troponin concentrations with analytical performance suitable for high-sensitivity clinical pathways.
What is delta troponin?
Delta troponin is the change between serial troponin measurements. It may be expressed as an absolute concentration change or a relative percentage change.
What delta confirms myocardial infarction?
There is no single universal delta that applies to every hs-cTn assay. Use the validated assay-specific algorithm and clinical context.
Can kidney disease increase troponin?
Yes. Patients with chronic kidney disease frequently have chronically elevated cardiac troponin concentrations. Serial change and the clinical picture are particularly important.
Can sepsis increase troponin?
Yes. Severe systemic illness and sepsis can produce genuine myocardial injury and elevated cardiac troponin.
Can pulmonary embolism increase troponin?
Yes. Significant pulmonary embolism may cause right ventricular strain and myocardial injury with elevated troponin.
Can myocarditis cause high troponin?
Yes. Myocardial inflammation can cause cardiac troponin release.
What causes false-positive troponin?
Possible causes include heterophile antibodies, other endogenous antibody interference, macrotroponin, and other assay-specific analytical effects.
Can biotin affect troponin testing?
Yes. Some susceptible assays may be affected by high circulating biotin concentrations. Importantly, falsely low troponin results have been reported with susceptible assay designs.
How can the laboratory investigate an unexpected troponin result?
Possible steps include confirming patient identification, reviewing QC and calibration, repeating the test, testing a fresh sample, using an alternative assay, and investigating interference with validated laboratory procedures.
Can troponin I and troponin T results be compared directly?
No. Results from different assays and platforms are not numerically interchangeable, and each method has its own decision limits.
Why are serial troponin samples important?
Serial samples help evaluate whether troponin is rising, falling, or relatively stable and therefore help distinguish acute from chronic myocardial injury.
30. References and Professional Resources
Thygesen K, et al. Circulation. 2018.
American Heart Association – Fourth Universal Definition of MI
European Society of Cardiology
International Federation of Clinical Chemistry and Laboratory Medicine
U.S. Food and Drug Administration
Resources on 99th percentile values, assay performance, and high-sensitivity cardiac troponin implementation.
Always consult the current assay-specific package insert or IFU for specimen requirements, analytical interferences, reference limits, calibration requirements, and performance characteristics.
31. Key Takeaways
- Cardiac troponin above the assay-specific 99th percentile indicates myocardial injury.
- A rise or fall in troponin supports acute myocardial injury.
- Myocardial infarction requires evidence of acute myocardial injury plus clinical evidence of ischemia.
- High troponin is not specific for acute coronary syndrome.
- Kidney disease, sepsis, heart failure, pulmonary embolism, myocarditis, arrhythmias, and other disorders can increase troponin.
- Delta values and accelerated algorithms are assay specific.
- Troponin I and troponin T results from different platforms should not be considered numerically interchangeable.
- Heterophile antibodies and macrotroponin are important causes of unexpected analytical elevation.
- Biotin can interfere with susceptible troponin assays and may produce dangerously misleading results, including falsely low values in some systems.
- Good QC, correct specimen identification, serial sampling, and clinician-laboratory communication are essential for safe troponin testing. For broader laboratory interpretation skills, readers may also review Complete Blood Count (CBC), Liver Function Tests (LFTs), and Thyroid Function Tests.
Never ask only, “Is troponin high?”
Ask: Which assay? What is its 99th percentile? Is the result changing? What is the delta? Is the injury acute or chronic? Is there evidence of ischemia? Does the laboratory result fit the clinical picture?
Prepared for: MedLab Academy
Last Updated: August 15, 2026